MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma

Jenny J. Li; Xiaoling Zhang; Neil Sankar; Lynn Espiritu; Sanjeev Redkar; Guo Liang Yu; Sani H. Kizilbash

doi:10.1200/PO.22.00096

MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma

Jenny J. Li, Xiaoling Zhang, Neil Sankar, Lynn Espiritu, Sanjeev Redkar, Guo Liang Yu, Sani H. Kizilbash

Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Article number	e2200096
Journal	JCO Precision Oncology
Volume	6
DOIs	https://doi.org/10.1200/PO.22.00096
State	Published - Jun 1 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/PO.22.00096

Cite this

@article{a23c5cfb479349d68e81cebb7e55bf04,

title = "MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma",

author = "Li, {Jenny J.} and Xiaoling Zhang and Neil Sankar and Lynn Espiritu and Sanjeev Redkar and Yu, {Guo Liang} and Kizilbash, {Sani H.}",

year = "2022",

month = jun,

day = "1",

doi = "10.1200/PO.22.00096",

language = "English (US)",

volume = "6",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma

AU - Li, Jenny J.

AU - Zhang, Xiaoling

AU - Sankar, Neil

AU - Espiritu, Lynn

AU - Redkar, Sanjeev

AU - Yu, Guo Liang

AU - Kizilbash, Sani H.

PY - 2022/6/1

Y1 - 2022/6/1

UR - http://www.scopus.com/inward/record.url?scp=85133702781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133702781&partnerID=8YFLogxK

U2 - 10.1200/PO.22.00096

DO - 10.1200/PO.22.00096

M3 - Article

C2 - 35675576

AN - SCOPUS:85133702781

SN - 2473-4284

VL - 6

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2200096

ER -

MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this